Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hypoxanthine |
Is a |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xanthine measurement |
Has measured component |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xanthine overdose |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline overdose (disorder) |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental aminophylline overdose |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional aminophylline overdose |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
surdose d'aminophylline d'intention indéterminée |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline overdose (disorder) |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental theophylline overdose |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional theophylline overdose |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
surdose de théophylline d'intention indéterminée |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xanthine measurement |
Component |
True |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Caffeine and sodium benzoate injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xanthine adverse reaction (disorder) |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline adverse reaction |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Choline theophyllinate adverse reaction (disorder) |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline adverse reaction (disorder) |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to xanthine (finding) |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to aminophylline (finding) |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
allergie au théophyllinate de choline |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to theophylline |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xanthine bronchodilators |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing xanthine (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Caffeine 5mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine citrate 20mg/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine citrate 20mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin + butalbital + caffeine 325mg/50mg/40mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine + ergotamine tartrate 100mg/1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine + ergotamine tartrate 100mg/2mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen+butalbital+caffeine 325mg/50mg/40mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen+butalbital+caffeine 500mg/50mg/40mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin + caffeine + orphenadrine citrate tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral caffeine (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing caffeine in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing caffeine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing caffeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin + oxtriphylline 50mg/100mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin + oxtriphylline 50mg/100mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing choline theophyllinate and guaifenesin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aspirin and butalbital and caffeine and codeine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing caffeine and isometheptene mucate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aspirin and caffeine and propoxyphene hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aspirin and caffeine and dihydrocodeine tartrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine + ergotamine tartrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine- and sodium benzoate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin + caffeine + orphenadrine citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing butalbital and caffeine and codeine phosphate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing choline theophyllinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aspirin and butalbital and caffeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xanthinol (substance) |
Is a |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine |
Is a |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methyl xanthine |
Is a |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Uric acid |
Is a |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diprophylline (substance) |
Is a |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theobromine (substance) |
Is a |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline (substance) |
Is a |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline (substance) |
Is a |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dimenhydrinate (substance) |
Is a |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentoxifylline |
Is a |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xanthine bronchodilator |
Is a |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline overdose (disorder) |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental aminophylline overdose |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional aminophylline overdose |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
surdose d'aminophylline d'intention indéterminée |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline overdose (disorder) |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental theophylline overdose |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional theophylline overdose |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
surdose de théophylline d'intention indéterminée |
Causative agent (attribute) |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline 100mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
aminophylline 25 mg/mL, ampoule de 10 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline 225mg modified release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline 350mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline 100mg modified release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
aminophylline 25 mg/mL, seringue préremplie de 10 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 10mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely theophylline monohydrate (as theophylline sodium glycinate) 12 milligram/1 milliliter conventional release oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 175mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 250mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 60mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 125mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 250mg m/r capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 300mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 400mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xanthine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|